Modular Medical, Inc. (NASDAQ:MODD – Get Free Report) CEO Manchester Management Co Llc acquired 10,000 shares of the stock in a transaction that occurred on Thursday, November 19th. The shares were bought at an average cost of $2.03 per share, with a total value of $20,300.00. Following the transaction, the chief executive officer directly owned 24,067 shares in the company, valued at $48,856.01. This trade represents a 71.09% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.
Modular Medical Stock Down 11.1%
Shares of NASDAQ MODD opened at $1.69 on Friday. The stock has a fifty day simple moving average of $2.02 and a 200-day simple moving average of $4.43. Modular Medical, Inc. has a twelve month low of $1.20 and a twelve month high of $16.20.
Modular Medical (NASDAQ:MODD – Get Free Report) last issued its quarterly earnings results on Monday, November 16th. The company reported ($0.90) earnings per share (EPS) for the quarter.
Analyst Ratings Changes
A number of analysts recently weighed in on MODD shares. Weiss Ratings restated a “sell (e+)” rating on shares of Modular Medical in a research note on Monday, September 21st. Wall Street Zen raised Modular Medical from a “strong sell” rating to a “sell” rating in a report on Sunday, August 23rd. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.
Read Our Latest Stock Report on MODD
Hedge Funds Weigh In On Modular Medical
An institutional investor recently raised its position in Modular Medical stock. AWM Investment Company Inc. boosted its stake in shares of Modular Medical, Inc. (NASDAQ:MODD – Free Report) by 20.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 441,095 shares of the company’s stock after buying an additional 74,429 shares during the quarter. AWM Investment Company Inc. owned 7.38% of Modular Medical worth $1,985,000 as of its most recent filing with the Securities and Exchange Commission. 27.47% of the stock is currently owned by institutional investors.
About Modular Medical
Modular Medical, Inc. is a medical-device company focused on developing insulin-delivery technology for people with diabetes. Its work centers on making pump therapy simpler and more accessible for people who may find traditional insulin pumps difficult to use. The company’s lead product, MODD1, is a wearable insulin-delivery system designed to provide an alternative to multiple daily insulin injections. Modular Medical describes the device as a simplified pump intended to make insulin delivery easier to manage.
Recommended Stories
- Five stocks we like better than Modular Medical
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
